COVID Risk | Literature database and meta-analysis page 13

Last update : 2021-08-05 08:37:15 (GMT+2) | 276 factors investigated | 1766 estimates included | 219 articles processed | QC progress: 50%

Receive updates on COVID-19 risk factors

Associated factors

Risk category:

Risk name:

Outcomes

Outcome description:

Filters

Adjusted analysis:

Author:

Reset
Run a meta-analysis by selecting an Outcome & a Risk category or a Risk name & a Risk category, and click on the Submit button.

Green: significant protective factor
Red: significant risk factor
^§ adjusted estimate (see article details)
^† estimated using data reported in the article

Outcome	Risk category	Risk [exposed vs. unexposed]	Risk estimate (95% CI)	Author [URL]	View	QC
COVID-19 (ventricular arrhythmias)	Treatment	Treatment for COVID-19 [Abnormal vs. Normal]	Hazard ratio: 1.008 (0.898-1.130) ^§	Mehra
COVID-19 (ventricular arrhythmias)	Complications	Sequential Organ Failure Assessment (SOFA) score [Abnormal vs. Normal]	Hazard ratio: 1.134 (0.984-1.308) ^§	Mehra
COVID-19 (ventricular arrhythmias)	Treatment	Oxygen Saturation (SpO2) [Abnormal vs. Normal]	Hazard ratio: 0.849 (0.710-1.016) ^§	Mehra
COVID-19 (ventricular arrhythmias)	Treatment	Treatment for COVID-19 [Treated with chloroquine alone vs. Not received]	Hazard ratio: 3.561 (2.760-4.596) ^§	Mehra
COVID-19 (ventricular arrhythmias)	Treatment	Treatment for COVID-19 [Treated with hydroxychloroquine alone vs. Not received]	Hazard ratio: 2.369 (1.935-2.900) ^§	Mehra
COVID-19 (ventricular arrhythmias)	Treatment	Treatment for COVID-19 [Treated with chloroquine and macrolide vs. Not received]	Hazard ratio: 4.011 (3.344-4.812) ^§	Mehra
COVID-19 (ventricular arrhythmias)	Treatment	Treatment for COVID-19 [Treated with hydroxychloroquine and macrolide vs. Not received]	Hazard ratio: 5.106 (4.357-5.983) ^§	Mehra
SARS COV-2 infection	Comorbidities	Immunocompromised [Present vs. Not present]	Odds ratio: 1.010 (0.780-1.310) ^§	Lusignan
SARS COV-2 infection	Comorbidities	Cancer [Present vs. Not present]	Odds ratio: 1.010 (0.780-1.310) ^§	Lusignan
SARS COV-2 infection	Comorbidities	Chronic respiratory disease [Present vs. Not present]	Odds ratio: 1.040 (0.720-1.500) ^§	Lusignan
SARS COV-2 infection	Comorbidities	Heart disease [Present vs. Not present]	Odds ratio: 1.210 (0.920-1.600) ^§	Lusignan
SARS COV-2 infection	Comorbidities	Diabetes [Present vs. Not present]	Odds ratio: 1.030 (0.780-1.360) ^§	Lusignan
SARS COV-2 infection	Comorbidities	Chronic kidney disease [Present vs. Not present]	Odds ratio: 1.910 (1.310-2.780) ^§	Lusignan
SARS COV-2 infection	Comorbidities	Hypertension [Present vs. Not present]	Odds ratio: 0.890 (0.690-1.140) ^§	Lusignan
SARS COV-2 infection	Patient characteristics	BMI [Severe obesity (>35kg/m2) vs. Normal (<25 kg/m2)]	Odds ratio: 1.280 (0.780-2.100) ^§	Lusignan
SARS COV-2 infection	Patient characteristics	BMI [Obesity (30-35kg/m2) vs. Normal (<25 kg/m2)]	Odds ratio: 1.410 (1.040-1.910) ^§	Lusignan
SARS COV-2 infection	Patient characteristics	BMI [Overweight (25-29kg/m2) vs. Normal (<25 kg/m2)]	Odds ratio: 1.260 (0.990-1.610) ^§	Lusignan
SARS COV-2 infection	Patient characteristics	Smoking [History of smoking vs. No history of smoking]	Odds ratio: 0.870 (0.690-1.100) ^§	Lusignan
SARS COV-2 infection	Patient characteristics	Smoking [Present vs. No history of smoking]	Odds ratio: 0.490 (0.340-0.710) ^§	Lusignan
SARS COV-2 infection	Patient characteristics	Location [Urban vs. Rural]	Odds ratio: 4.590 (3.570-5.900) ^§	Lusignan
SARS COV-2 infection	Patient characteristics	Household size [>=9 vs. 1]	Odds ratio: 1.290 (0.800-2.070) ^§	Lusignan
SARS COV-2 infection	Patient characteristics	Household size [5-8 vs. 1]	Odds ratio: 0.860 (0.570-1.310) ^§	Lusignan
SARS COV-2 infection	Patient characteristics	Household size [2-4 vs. 1]	Odds ratio: 0.970 (0.770-1.230) ^§	Lusignan
SARS COV-2 infection	Patient characteristics	Socioeconomic deprivation level [1 and 2 (most deprived) vs. 5 (least deprived)]	Odds ratio: 2.030 (1.510-2.710) ^§	Lusignan
SARS COV-2 infection	Patient characteristics	Socioeconomic deprivation level [3 vs. 5 (least deprived)]	Odds ratio: 2.350 (1.780-3.110) ^§	Lusignan
SARS COV-2 infection	Patient characteristics	Socioeconomic deprivation level [4 vs. 5 (least deprived)]	Odds ratio: 1.510 (1.130-2.030) ^§	Lusignan
SARS COV-2 infection	Patient characteristics	Ethnicity [Mixed vs. White]	Odds ratio: 1.710 (0.970-3.010) ^§	Lusignan
SARS COV-2 infection	Patient characteristics	Ethnicity [Black vs. White]	Odds ratio: 4.750 (2.650-8.510) ^§	Lusignan
SARS COV-2 infection	Patient characteristics	Ethnicity [Asian vs. White]	Odds ratio: 1.460 (0.940-2.290) ^§	Lusignan
SARS COV-2 infection	Patient characteristics	Gender [Male vs. Female]	Odds ratio: 1.550 (1.270-1.890) ^§	Lusignan
SARS COV-2 infection	Patient characteristics	Age [>=75 years vs. 0-17 years]	Odds ratio: 5.230 (3.000-9.090) ^§	Lusignan
SARS COV-2 infection	Patient characteristics	Age [65–74 years vs. 0-17 years]	Odds ratio: 4.410 (2.520-7.690) ^§	Lusignan
SARS COV-2 infection	Patient characteristics	Age [40–64 years vs. 0-17 years]	Odds ratio: 5.360 (3.280-8.760) ^§	Lusignan
SARS COV-2 infection	Patient characteristics	Age [18–39 years vs. 0-17 years]	Odds ratio: 2.830 (1.690-4.740) ^§	Lusignan
COVID-19 (death)	Status	Time from symptom onset to hospital admission [1 day increase vs. Not applicable]	Hazard ratio: 1.010 (0.960-1.050) ^§	Cummings
COVID-19 (death)	Laboratory Findings	D-dimer [1 unit increase vs. Not applicable]	Hazard ratio: 1.100 (1.010-1.190) ^§	Cummings
COVID-19 (death)	Laboratory Findings	IL-6 [1 unit increase vs. Not applicable]	Hazard ratio: 1.110 (1.020-1.200) ^§	Cummings
COVID-19 (death)	Comorbidities	Diabetes [Present vs. Not present]	Hazard ratio: 1.310 (0.810-2.100) ^§	Cummings
COVID-19 (death)	Comorbidities	COPD [Present vs. Not present]	Hazard ratio: 2.940 (1.480-5.840) ^§	Cummings
COVID-19 (death)	Comorbidities	Chronic cardiac disease [Present vs. Not present]	Hazard ratio: 1.760 (1.080-2.860) ^§	Cummings
COVID-19 (death)	Comorbidities	Hypertension [Present vs. Not present]	Hazard ratio: 1.580 (0.890-2.810) ^§	Cummings
COVID-19 (death)	Patient characteristics	Gender [Male vs. Female]	Hazard ratio: 1.130 (0.710-1.810) ^§	Cummings
COVID-19 (death)	Patient characteristics	Age [10 year increase vs. Not applicable]	Hazard ratio: 1.310 (1.090-1.570) ^§	Cummings
COVID-19 (clinical improvement)	Comorbidities	Any comorbidity [Present vs. Not present]	Odds ratio: 1.322 (0.201-8.693) ^§	Cai
COVID-19 (clinical improvement)	Symptoms	Fever [Present vs. Not present]	Odds ratio: 3.622 (1.054-12.442) ^§	Cai
COVID-19 (clinical improvement)	Treatment	Treatment for COVID-19 [Treated with favipiravir vs. Treated with lopinavir/ritonavir]	Odds ratio: 3.190 (1.041-9.780) ^§	Cai
COVID-19 (clinical improvement)	Patient characteristics	Age [1 unit increase vs. Not applicable]	Odds ratio: 0.981 (0.947-1.016) ^§	Cai
COVID-19 in children (severe/critical)	Symptoms	Digestive symptoms [Present vs. Not present]	Odds ratio: 2.570 (1.070-6.160)	Lu
COVID-19 in children (severe/critical)	Symptoms	Cough and dyspnea [Present vs. Not present]	Odds ratio: 2.290 (1.050-5.030)	Lu
COVID-19 in children (severe/critical)	Symptoms	Fever [Present vs. Not present]	Odds ratio: 5.140 (2.190-12.010)	Lu

If a relevant publication escaped our attention, please contact us.